Selecting the particle size distribution for drugs with low water solubility – mathematical model

References

• Kasim NA, Whitehouse M, Ramachandran C, Bermejo M, Lennernäs H, Hussain AS et al. (2004). Molecular properties of WHO essential drugs and provisional biopharmaceutical classification. Mol Pharm, 1:85–96.
   PubMed Web of Science ®Google Scholar
• Noyes A, Whitney W. (1897). The rate of solution of solid substrate in their own solutions. J Am Chem Soc, 19:930–934.
   Google Scholar
• Yu LX. (1999). An integrated model for determining causes of poor oral drug absorption. Pharm Res, 16:1883–1887.
   PubMed Web of Science ®Google Scholar
• Willmann S, Schmitt W, Keldenich J, Lippert J, Dressman JB. (2004). A physiological model for the estimation of the fraction dose absorbed in humans. J Med Chem, 47:4022–4031.
   PubMed Web of Science ®Google Scholar
• Ho NFH, Park JY, Ni PF, Higuchi WI. (1983). Advancing quantitative and mechanistic approaches in interfacing gastrointestinal drug absorption studies animals and human. In Crouthamel W, Sarapu AC, eds. Animal Models for Oral Drug Delivery in Man: In Situ and In Vivo Approaches. Washington D.C.: American Pharmaceutical Association, 27–103.
   Google Scholar
• Agoram B, Woltosz WS, Bolger MB. (2001). Predicting the impact of physiological and biochemical processes on oral drug bioavailability. Adv Drug Deliv Rev, 50 Suppl 1:S41–S67.
   PubMed Web of Science ®Google Scholar
• Johnson KC. (2003). Dissolution and absorption modeling: model expansion to simulate the effects of precipitation, water absorption, longitudinally changing intestinal permeability, and controlled release on drug absorption. Drug Dev Ind Pharm, 29:833–842.
   PubMed Web of Science ®Google Scholar
• Hintz R, Johnson K. (1989). The effect of particle size distribution on dissolution rate and oral absorption. Int J Pharm, 51:517–519.
   Google Scholar
• Takano R, Sugano K, Higashida A, Hayashi Y, Machida M, Aso Y et al. (2006). Oral absorption of poorly water-soluble drugs: computer simulation of fraction absorbed in humans from a miniscale dissolution test. Pharm Res, 23:1144–1156.
   PubMed Web of Science ®Google Scholar
• Mathews B, Rhodes C. (1967). Particle size of commercial griseofulvin with reference to official standards. J Pharm Sci, 56:838–842.
   PubMed Web of Science ®Google Scholar
• Yu L, Crison J, Amidon G. (1995). A strategic approach for predicting for predicting oral drug absorption. Pharm Res, 12:S8–S8.
   Google Scholar
• Yu LX, Lipka E, Crison JR, Amidon GL. (1996). Transport approaches to the biopharmaceutical design of oral drug delivery systems: prediction of intestinal absorption. Adv Drug Deliv Rev, 19:359–376.
   PubMed Web of Science ®Google Scholar
• Bhaskarwar A. (1989). General-population balance model of dissolution of polydisperse particles. AIChE J, 35:658–661.
   Web of Science ®Google Scholar
• Leblanc S, Fogler H. (1987). Population balance modeling of the dissolution of polydisperse solids - rate limiting regimes. AIChE J, 33:54–63.
   Web of Science ®Google Scholar
• Mangin D, Garcia E, Gerard S, Hoff C, Klein J, Veesler S. (2006). Modeling of the dissolution of a pharmaceutical compound. J Cryst Growth, 286:121–125.
   Web of Science ®Google Scholar
• Ozturk SS, Palsson BO, Dressman JB. (1988). Dissolution of ionizable drugs in buffered and unbuffered solutions. Pharm Res, 5:272–282.
   PubMed Web of Science ®Google Scholar
• Higuchi WI, Hiestand EN. (1963). Dissolution rates of finely divided drug powders. I. Effect of a distribution of particle sizes in a diffusion-controlled process. J Pharm Sci, 52:67–71.
   PubMed Web of Science ®Google Scholar
• Harriott P. (1962). Mass transfer to particles. I. Suspended in agitated tanks. AIChE J, 8:93–101.
   Web of Science ®Google Scholar
• Okazaki A, Mano T, Sugano K. (2008). Theoretical dissolution model of poly-disperse drug particles in biorelevant media. J Pharm Sci, 97:1843–1852.
   PubMed Web of Science ®Google Scholar
• Charman WN, Porter CJ, Mithani S, Dressman JB. (1997). Physiochemical and physiological mechanisms for the effects of food on drug absorption: the role of lipids and pH. J Pharm Sci, 86:269–282.
   PubMed Web of Science ®Google Scholar
• Oberle RL, Chen TS, Lloyd C, Barnett JL, Owyang C, Meyer J et al. (1990). The influence of the interdigestive migrating myoelectric complex on the gastric emptying of liquids. Gastroenterology, 99:1275–1282.
   PubMed Web of Science ®Google Scholar
• Davis SS, Hardy JG, Fara JW. (1986). Transit of pharmaceutical dosage forms through the small intestine. Gut, 27:886–892.
   PubMed Web of Science ®Google Scholar
• Priebe MG, Wachters-Hagedoorn RE, Stellaard F, Heiner AM, Elzinga H, Vonk RJ. (2004). Oro-cecal transit time: influence of a subsequent meal. Eur J Clin Invest, 34:417–421.
   PubMed Web of Science ®Google Scholar
• DeSesso JM, Jacobson CF. (2001). Anatomical and physiological parameters affecting gastrointestinal absorption in humans and rats. Food Chem Toxicol, 39:209–228.
   PubMed Web of Science ®Google Scholar
• Lennernas H, Palm K, Fagerholm U, Artursson P. (1996). Comparison between active and passive drug transoprt in human intestinal epithelial (Caco-2) cells in vitro and human jejenum in vivo. Int J Pharm 127:103–107.
   Web of Science ®Google Scholar
• Watts P, Illum L. (1997). Colonic drug delivery. Drug Dev Ind Pharm, 23:813–913.
   Google Scholar
• Yu L, Crison J, Amidon G. (1996). Compartmental transit and dispersion model analysis of small intestine transit flow in humans. Int J Pharm, 140:111–118.
   Web of Science ®Google Scholar
• Dressman JB, Fleisher D. (1986). Mixing-tank model for predicting dissolution rate control or oral absorption. J Pharm Sci, 75:109–116.
   PubMed Web of Science ®Google Scholar
• Zhao YH, Abraham MH, Le J, Hersey A, Luscombe CN, Beck G et al. (2002). Rate-limited steps of human oral absorption and QSAR studies. Pharm Res, 19:1446–1457.
   PubMed Web of Science ®Google Scholar
• Fujiwara S, Yamashita F, Hashida M. (2002). Prediction of Caco-2 cell permeability using a combination of MO-calculation and neural network. Int J Pharm, 237:95–105.
   PubMed Web of Science ®Google Scholar
• Dressman JB, Reppas C. (2000). In vitro-in vivo correlations for lipophilic, poorly water-soluble drugs. Eur J Pharm Sci, 11 Suppl 2:S73–S80.
   PubMed Web of Science ®Google Scholar
• Watanabe E, Takahashi M, Hayashi M. (2004). A possibility to predict the absorbability of poorly water-soluble drugs in humans based on rat intestinal permeability assessed by an in vitro chamber method. Eur J Pharm Biopharm, 58:659–665.
   PubMed Web of Science ®Google Scholar
• Rowland M, Tozer T. (1995). Clinical pharmacokinetics. Baltimore: Lippinicott Williams & Wilkins.
   Google Scholar
• Shaw TR, Carless JE. (1974). The effect of particle size on the absorption of digoxin. Eur J Clin Pharmacol, 7:269–273.
   PubMed Web of Science ®Google Scholar
• Marchuk G. (1990). Splitting and alternating direction methods. In Ciarlet P, Lions JL, eds. Handbook of Numerical Analysis. North-Holland: Elsevier science publishers B.V.
   Google Scholar
• Leveque R. (2002). Finite volume methods for hyperbolic problems. Cambridge: Cambridge University Press.
   Google Scholar
• Crank J. (1975). The mathematics of diffusion. Oxford: Clarendon Press.
   Google Scholar
• MathWorks. (2007a). Matlab Technical report. Natick: The MathWorks Inc.
   Google Scholar
• Lu AT, Frisella ME, Johnson KC. (1993). Dissolution modeling: factors affecting the dissolution rates of polydisperse powders. Pharm Res, 10:1308–1314.
   PubMed Web of Science ®Google Scholar
• Chiou WL, Riegelman S. (1971). Absorption characteristics of solid dispersed and micronized griseofulvin in man. J Pharm Sci, 60:1376–1380.
   PubMed Web of Science ®Google Scholar
• Kraml M, Dubuc J, Gaudry R. (1962). Gastrointestinal absorption of griseofulvin. II. Influence of particle size in man. Antibiot Chemother, 12:239–242.
   Google Scholar
• Kabasakalian P, Katz M, Rosenkrantz B, Townley E. (1970). Parameters affecting absorption of griseofulvin in a human subject using urinary metabolite excretion data. J Pharm Sci, 59:595–600.
   PubMed Web of Science ®Google Scholar
• Yu LX, Amidon GL. (1999). A compartmental absorption and transit model for estimating oral drug absorption. Int J Pharm, 186:119–125.
   PubMed Web of Science ®Google Scholar
• Straughn AB, Meyer MC, Raghow G, Rotenberg K. (1980). Bioavailability of microsize and ultramicrosize griseofulvin products in man. J Pharmacokinet Biopharm, 8:347–362.
   PubMedGoogle Scholar
• Yazdanian M, Glynn SL, Wright JL, Hawi A. (1998). Correlating partitioning and caco-2 cell permeability of structurally diverse small molecular weight compounds. Pharm Res, 15:1490–1494.
   PubMed Web of Science ®Google Scholar
• Takagi T, Ramachandran C, Bermejo M, Yamashita S, Yu LX, Amidon GL. (2006). A provisional biopharmaceutical classification of the top 200 oral drug products in the United States, Great Britain, Spain, and Japan. Mol Pharm, 3:631–643.
   PubMed Web of Science ®Google Scholar
• Aoyagi N, Ogata H, Kaniwa N, Ejima A. (1982). Effect of food on the bioavailability of griseofulvin from microsize and PEG ultramicrosize (GRIS-PEG) plain tablets. J Pharmacobio-dyn, 5:120–124.
   PubMedGoogle Scholar
• Aoyagi N, Ogata H, Kaniwa N, Koibuchi M, Shibazaki T, Ejima A. (1982). Bioavailability of griseofulvin from tablets in humans and the correlation with its dissolution rate. J Pharm Sci, 71:1165–1169.
   PubMed Web of Science ®Google Scholar
• Barret W, Bianchine J. (1975). The biovailability of ultramicronized griseofulvin (Gris-PEG) tablets in man. Curr Ther Res Clin Exp, 18:501–509.
   PubMed Web of Science ®Google Scholar
• Hidalgo IJ, Raub TJ, Borchardt RT. (1989). Characterization of the human colon carcinoma cell line (Caco-2) as a model system for intestinal epithelial permeability. Gastroenterology, 96:736–749.
   PubMed Web of Science ®Google Scholar
• Gramatté T. (1994). Griseofulvin absorption from different sites in the human small intestine. Biopharm Drug Dispos, 15:747–759.
   PubMed Web of Science ®Google Scholar